Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Dr. Terrault discusses results from key viral hepatitis studies reported at the American Association for the Study of Liver Diseases (AASLD) 2020 annual conference, The Liver Meeting Digital Experience, including new findings on HBV treatment and management, hepatocellular carcinoma risk, and emerging approaches to HCV care in underserved populations.
Norah Terrault, MD, MPH
Professor of Medicine
Chief of Gastrointestinal and Liver Diseases
University of Southern California
Los Angeles, California
Download slides reviewing the latest data and guidance on approaches to managing patients with hepatitis delta virus (HDV), from Clinical Care Options (CCO)
Dr Robert G. Gish: whom and how to test for hepatitis delta virus (HDV), from Clinical Care Options (CCO)
Review key slides on the interplay of COVID-19 and viral hepatitis and review expert strategies for managing chronic liver disease in the COVID-19 era
Clinical Care Options (CCO) commentary by Dr. Dominique Braun on the results of the Swiss HCVree Trial: HCV testing, treatment, and counseling in MSM with HIV and HCV